acetylcysteine in treatment of infertile women with polycystic ovarian syndrome

Phase 3

• Conditions: Condition 1: infertility in polycystic ovarian syndrome. Condition 2: .; polycystic ovarian syndrome; Female infertility associated with anovulation

• Registration Number: IRCT2014050617593N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

inclusion criteria: infertile women with PCOS (according to ESHRE/ASRM criteria) with normal hysterosalpingographies, normal spermograms of partners, and not impaired sexual functions
exclusion criteria: ovarian cyst >6 cm, history of asthma or allergy, consumption of any drugs with effects on glucose metabolism during the last 3 months before entering the trial.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ovulation rate. Timepoint: 7 days after intervention (14th day of menstrual cycle). Method of measurement: detecting at least one 18 mm follicle or larger in vaginal ultrasonography.;Pregnancy rate. Timepoint: 23 days after intervention (30th day of menstrual cycle). Method of measurement: laboratory measurement of hCG-ß level.

Secondary Outcome Measures

Name	Time	Method
Endometrial thickness. Timepoint: 7 days after intervention (14th day of menstrual cycle). Method of measurement: measuring endometrial thickness by means of vaginal ultrasonography (millimeters).